about
6-Hydroxydopamine induces distinct alterations in GDF5 and GDNF mRNA expression in the rat nigrostriatal system in vivo.Regulation of sympathetic neuron differentiation by endogenous nerve growth factor and neurotrophin-3.Macrophage stimulating protein is a neurotrophic factor for a sub-population of adult nociceptive sensory neurons.Selective regulation of axonal growth from developing hippocampal neurons by tumor necrosis factor superfamily member APRILSelective regulation of nerve growth factor expression in developing cutaneous tissue by early sensory innervationProNGF promotes neurite growth from a subset of NGF-dependent neurons by a p75NTR-dependent mechanismExpression of endogenous Mkp1 in 6-OHDA rat models of Parkinson's disease.The neurite growth inhibitory effects of soluble TNFα on developing sympathetic neurons are dependent on developmental age.Regulation of Autocrine Signaling in Subsets of Sympathetic Neurons Has Regional Effects on Tissue Innervation.ERK signaling mediates CaSR-promoted axon growth.Region-specific role of growth differentiation factor-5 in the establishment of sympathetic innervation.T-type Ca2+ channels are required for enhanced sympathetic axon growth by TNFα reverse signallingNovel class of pain drugs based on antagonism of NGF.Regulation of neurite growth by tumour necrosis superfamily member RANKL.Zeb2 is a negative regulator of midbrain dopaminergic axon growth and target innervation.Role of STAT3 and PI 3-kinase/Akt in mediating the survival actions of cytokines on sensory neurons.Macrophage stimulating protein is a target-derived neurotrophic factor for developing sensory and sympathetic neurons.TNF superfamily member APRIL enhances midbrain dopaminergic axon growth and contributes to the nigrostriatal projection in vivo.An essential role for neuregulin-4 in the growth and elaboration of developing neocortical pyramidal dendrites.Canonical BMP-Smad signalling promotes neurite growth in rat midbrain dopaminergic neurons.Mitogen-activated protein kinase phosphatase (MKP)-1 as a neuroprotective agent: promotion of the morphological development of midbrain dopaminergic neurons.Knockdown of interleukin-1 receptor 1 is not neuroprotective in the 6-hydroxydopamine striatal lesion rat model of Parkinson's disease
P50
Q31146747-93660CD9-F998-4967-910D-78EEB09B161DQ33312540-547F0FC8-D9A5-47C6-A9EE-DBA1DC8D2C4FQ33418064-B9F657CD-AD27-4F7B-9C55-4EFD87464C79Q33559757-428FD577-61CB-4F00-A571-CA5764A73CFCQ33884934-70DD467C-8889-4FBC-89D1-D3089CCCCFABQ34697589-E08CAB64-BF74-4890-A695-42EFCC8B921DQ35168296-AE466250-8506-4FEF-9788-82E3C17198B7Q35541876-B89DDCC9-A119-44E7-83A2-DF1DA5E7250AQ35574017-FE284EF4-5406-496C-8A8F-50B318D3A7E2Q35705099-A2FB7B2B-DEAA-4BA1-8936-39BAD4E77FF4Q35924134-9B686434-984F-460B-9E32-8A351D00B038Q36253337-E3D18A9E-16A6-4813-8C1F-5C2E68D08226Q36352971-D5D8FB27-462C-489F-B6D7-618B943E43B1Q36702425-DE8C5E08-4690-491C-9C6F-6E17419C642DQ38368133-7ACD77B5-FED2-4CEC-853C-43567A919871Q43759578-484954F0-2BBC-4CFA-99F6-5765F244075FQ44285297-07945025-9C14-4301-8983-252E19057671Q47138321-8CEC132A-AA80-4C1F-B728-153697F1E465Q47660115-25FF2655-473B-42D5-BCE8-877142110F7AQ50674031-BDF0F3BE-3BCC-4ADB-AC8E-9EC331A0F013Q50748800-E96174C3-9DB6-4791-8A21-0249E4A2073AQ63413110-A5BE558A-8533-48B0-85ED-1A3751CB8771
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sean Wyatt
@ast
Sean Wyatt
@en
Sean Wyatt
@es
Sean Wyatt
@nl
Sean Wyatt
@sl
type
label
Sean Wyatt
@ast
Sean Wyatt
@en
Sean Wyatt
@es
Sean Wyatt
@nl
Sean Wyatt
@sl
prefLabel
Sean Wyatt
@ast
Sean Wyatt
@en
Sean Wyatt
@es
Sean Wyatt
@nl
Sean Wyatt
@sl
P106
P1153
7005406818
P21
P31
P496
0000-0002-0572-234X